These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 511973)

  • 1. Cholesterol metabolism in diabetes: the effect of insulin on the kinetics of plasma squalene.
    Frier BM; Saudek CD
    J Clin Endocrinol Metab; 1979 Dec; 49(6):824-9. PubMed ID: 511973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of cholesterol synthesis in man by isotope kinetics of squalene.
    Liu GC; Ahrens EH; Schreibman PH; Samuel P; McNamara DJ; Crouse JR
    Proc Natl Acad Sci U S A; 1975 Nov; 72(11):4612-6. PubMed ID: 1060141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of daily cholesterol synthesis rates in man by assay of the fractional conversion of mevalonic acid to cholesterol.
    McNamara DJ; Ahrens EH; Samuel P; Crouse JR
    Proc Natl Acad Sci U S A; 1977 Jul; 74(7):3043-6. PubMed ID: 268653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of different components in the fractional conversion of mevalonate to cholesterol with cholesterol synthesis and serum methyl sterols.
    Miettinen TA; Tilvis R
    Scand J Clin Lab Invest; 1981 Sep; 41(5):507-12. PubMed ID: 7313530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the kidneys in the metabolism of plasma mevalonate. Studies in humans and in rhesus monkeys.
    McNamara DJ; Ahrens EH; Parker TS; Morrissey K
    J Clin Invest; 1985 Jul; 76(1):31-9. PubMed ID: 4019781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Activities of 3-hydroxy-3-methylglutaryl-CoA reductase and acetyl-CoA carboxylase and rate of biosynthesis of mevalonic acid, squalene, sterols and fatty acids from [1-14C]acetyl-CoA and [2-14C]malonyl-CoA in rat liver: changes induced by daily rhythm].
    Poliakova ED; Dizhe EB; Klimova TA; Denisenko TV; Vasil'eva LE
    Biokhimiia; 1981 Jan; 46(1):126-39. PubMed ID: 6113851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The validity of serum squalene and non-cholesterol sterols as surrogate markers of cholesterol synthesis and absorption in type 2 diabetes.
    Simonen P; Gylling H; Miettinen TA
    Atherosclerosis; 2008 Apr; 197(2):883-8. PubMed ID: 17875306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posthatching evolution of in vivo mevalonate metabolism in chick liver.
    Aguilera JA; García-Molina V; Linares A; Arce V; García-Peregrin E
    Biochem Int; 1987 Feb; 14(2):375-83. PubMed ID: 3579966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma squalene: lipoprotein distribution and kinetic analysis.
    Saudek CD; Frier BM; Liu GC
    J Lipid Res; 1978 Sep; 19(7):827-35. PubMed ID: 712242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The distribution of squalene and non-cholesterol sterols in lipoproteins in type 2 diabetes.
    Simonen PP; Gylling H; Miettinen TA
    Atherosclerosis; 2007 Sep; 194(1):222-9. PubMed ID: 16963050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of the in vivo metabolism of mevalonic acid in the normal rat.
    Hellstrom KH; Siperstein MD; Bricker LA; Luby LJ
    J Clin Invest; 1973 Jun; 52(6):1303-13. PubMed ID: 4703220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced synthesis of cholesterol and its precursors in jejunal mucosa in coeliac disease.
    Vuoristo M; Miettinen TA
    Gut; 1986 Apr; 27(4):399-404. PubMed ID: 3957109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of diabetes mellitus on cholesterol metabolism in man.
    Bennion LJ; Grundy SM
    N Engl J Med; 1977 Jun; 296(24):1365-71. PubMed ID: 870827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fate of intravenously administered squalene in the rat.
    Tilvis RS; Miettinen TA
    Biochim Biophys Acta; 1982 Aug; 712(2):374-81. PubMed ID: 7126611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro.
    Flint OP; Masters BA; Gregg RE; Durham SK
    Toxicol Appl Pharmacol; 1997 Jul; 145(1):91-8. PubMed ID: 9221828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visceral obesity is associated with high levels of serum squalene.
    Peltola P; Pihlajamäki J; Koutnikova H; Ruotsalainen E; Salmenniemi U; Vauhkonen I; Kainulainen S; Gylling H; Miettinen TA; Auwerx J; Laakso M
    Obesity (Silver Spring); 2006 Jul; 14(7):1155-63. PubMed ID: 16899796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosynthesis of cholesterol in rabbit reticulocytes and its exchange with plasma.
    Sloviter HA; Janic V; Cirkovic T
    J Lipid Res; 1970 Mar; 11(2):82-6. PubMed ID: 5418482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma squalene as an index of cholesterol synthesis.
    Nestel PJ; Kudchodkar B
    Clin Sci Mol Med; 1975 Dec; 49(6):621-4. PubMed ID: 1204294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase.
    Amin D; Rutledge RZ; Needle SN; Galczenski HF; Neuenschwander K; Scotese AC; Maguire MP; Bush RC; Hele DJ; Bilder GE; Perrone MH
    J Pharmacol Exp Ther; 1997 May; 281(2):746-52. PubMed ID: 9152381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Squalene, lanosterol and cholesterol synthesis from acetate in neonatal chick tissues.
    Linares A; Arce V; Aguilera JA; García-Peregrín E
    Rev Esp Fisiol; 1984 Dec; 40(4):425-9. PubMed ID: 6531508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.